Indonesia is called absolute and must be able to have its own drugs and vaccines for Covid-19. The case in Ciseeng, Bogor Regency is an example of the need for speed in handling Covid-19 in tests and treatment.
The Chairman of the PAN Expert Council, Dradjad Wibowo in the Ciseeng case, Bogor regency became evidence of the necessity and cruciality of the massive and rapid Covid-19 test. Just a little late, so many people have the potential to contract Covid-19. "I often convey how crucial co-19 tests are," Dradjad said in his Watsapp message to republika.co.id, Tuesday (11/4).
One Ciseeng resident died, initially suspected of having a heart. Maybe because of the clinical symptoms, the doctor took a swab test. On the 8th day after the funeral, the deceased was found positive by the corona. Even though the funeral was done without COVID-19 procedure. Family and neighbors in the village are also tahlilan. As a result they are now ODP.
"In Ciseeng, Bogor, which is very close to Jakarta, it takes 8 days. What about other areas far away?" said Dradjad.
From that case, said Dradjad, only because of the slowness of the test, many people could be infected. Including of course the doctors, nurses and non-medical personnel of the hospital. "So again, tests and tests. As much as possible, as soon as possible," said the INDEF economy.
With such a test performance, Dradjad worried that the number of COVID-19 patients in Indonesia could be overwhelming. "Unless, there is a miracle from God, whether through heat and rain, or other His secrets," he said.
The trouble, continued Dradjad, is that our health service capacity is very limited. The number and quality of isolation rooms, PPE, ventilators and so on is limited. "Therefore, it is absolutely essential for Indonesia to have its own medicines and vaccines. This is a fixed price," said Dradjad.
According to him, Indonesia cannot rely on vaccines from other countries. The world population is now nearly 7.8 billion. Global demand for corona vaccines will amount to billions.
Developed countries vaccine inventor certainly prioritizes its citizens. The price can be expensive. Though at least 163 million people in Indonesia must be vaccinated to achieve herd immunity.
"That's the SARS-CoV-2 vaccine. With the mutation speed of various corona viruses, it may be necessary to have several types of vaccines and drugs," he said.
Dradjad reminded, now some scientists have thought about how the global landscape is post-corona or AC (after coronavirus). For example, automation and robotization will increasingly master the production process. Health services, pharmaceuticals, biology, the medical device industry, health insurance and other related businesses will be increasingly important.
On the other hand, continued Dradjad, Indonesia is rich in biodiversity as a drug and vaccine ingredient. This is Indonesia's comparative advantage, which has often been damaged unsustainably.
Regarding medicine, said Dradjad, Indonesia has joined the WHO Solidarity Trial. There are 4 drugs that are tried, namely remdesivir, chloroquine or hydroxychlorokuin, kaletra (a combination of lopinavir + ritonavir) and kaletra + interferon beta.
Indonesia uses chloroquine more. "I don't know yet how this will affect the fatality level of Covid-19. If other drugs are found to be more effective, of course Indonesia must import more," said the senior economist.
So, according to Dradjad, owning drugs and vaccines is a very urgent health and economic policy synergy. Therefore Dradjad suggested, provided large funds for the discovery and production of drugs and vaccines. "Move health and pharmaceutical SOEs, various biology-based research, scientists in various branches of biology, research doctors and so on," said Dradjad.
If Indonesia can suppress the corona outbreak, let alone be able to take advantage of the opportunities behind the outbreak, according to Dradjad, confidence in Indonesia's economy will quickly recover.
No comments:
Post a Comment